Literature DB >> 1719111

Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI.

P S Hansen1, N Rüdiger, A Tybjaerg-Hansen, O Faergeman, N Gregersen.   

Abstract

A single primer-template mismatch 2 bp from the apoB-3500 (G to A) mutation permits introduction of a cleavage site for MspI (C/CGG) in normal alleles but not in mutant alleles (CCAG). After amplification, cleavage, and polyacrylamide gel electrophoresis, normal and mutant alleles could be unambiguously distinguished. We constructed a positive (homozygous mutant) standard by site-directed mutagenesis. A negative standard was DNA from a homozygous normal subject. The method enables us to screen for the mutation with 12 microliters of spotted whole blood as the source of DNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719111

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  First International Workshop on Familial Defective apo B-100, Munich, November 1991.

Authors:  H Schuster; S Humphries; G Rauh; C Keller
Journal:  Clin Investig       Date:  1992-10

Review 2.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Authors:  Masa-aki Kawashiri; Kenshi Hayashi; Tetsuo Konno; Noboru Fujino; Hidekazu Ino; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-08-02       Impact factor: 2.037

3.  Detection of apoB-100 R3500Q mutation by competitive allele-specific polymerase chain reaction.

Authors:  A D Horvath; S A Kirov; E E Karaulanov; V S Ganev
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

4.  Recurrent and novel LDL receptor gene mutations causing heterozygous familial hypercholesterolemia in La Habana.

Authors:  E Pereira; R Ferreira; B Hermelin; G Thomas; C Bernard; V Bertrand; H Nassiff; D Mendez del Castillo; G Bereziat; P Benlian
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

5.  Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948.

Authors:  P S Hansen; L U Gerdes; I C Klausen; N Gregersen; O Faergeman
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

6.  Treatment of patients with familial defective apolipoprotein B-100 with pravastatin and gemfibrozil: a two-period cross-over study.

Authors:  P S Hansen; H Meinertz; L U Gerdes; I C Klausen; O Faergeman
Journal:  Clin Investig       Date:  1994-12

7.  Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.

Authors:  W März; M W Baumstark; H Scharnagl; V Ruzicka; S Buxbaum; J Herwig; T Pohl; A Russ; L Schaaf; A Berg
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  An efficient screening procedure detecting six novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia.

Authors:  U Ekström; M Abrahamson; T Sveger; P Lombardi; P Nilsson-Ehle
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

9.  Two mutations in LDLR gene were found in two Chinese families with familial hypercholesterolemia.

Authors:  Xiaohuan Cheng; Junfa Ding; Fang Zheng; Xin Zhou; Chenling Xiong
Journal:  Mol Biol Rep       Date:  2008-11-20       Impact factor: 2.316

10.  I/D polymorphism at the locus for ACE and apo A-I gene promoter polymorphism as risk factors for coronary artery disease in patients with familial hypercholesterolemia.

Authors:  D Petrovic; I Kleber; M Zorc; B Peterlin
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.